世界の脳バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Brain Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3930 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、脳バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイオマーカー検査キット、バイオマーカー分析装置）、用途別市場規模（病院、外来外科センター、診断研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・脳バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・脳バイオマーカーの種類別市場規模と予測2016-2027（バイオマーカー検査キット、バイオマーカー分析装置） ・脳バイオマーカーの用途別市場規模と予測2016-2027（病院、外来外科センター、診断研究所） ・脳バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・脳バイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・脳バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Philips、Johnson & Johnson、Roche、Seimens、GE、NeuroVista、Qiagen、Lifesign、Natus、BrainScope） ・結論

Brain Biomarkers are measurable indicators that measure the severity of brain in diseased state. 

Market Analysis and Insights: Global Brain Biomarker Market
The global Brain Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brain Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brain Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brain Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brain Biomarker market.

Global Brain Biomarker Scope and Market Size
Brain Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brain Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biomarker Test Kits
Biomarker Analyzers

Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Philips
Johnson & Johnson
Roche
Seimens
GE
NeuroVista
Qiagen
Lifesign
Natus
BrainScope

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biomarker Test Kits
1.2.3 Biomarker Analyzers
1.3 Market by Application
1.3.1 Global Brain Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Brain Biomarker Market Perspective (2016-2027)
2.2 Brain Biomarker Growth Trends by Regions
2.2.1 Brain Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Brain Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Brain Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Brain Biomarker Industry Dynamic
2.3.1 Brain Biomarker Market Trends
2.3.2 Brain Biomarker Market Drivers
2.3.3 Brain Biomarker Market Challenges
2.3.4 Brain Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Brain Biomarker Players by Revenue
3.1.1 Global Top Brain Biomarker Players by Revenue (2016-2021)
3.1.2 Global Brain Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Brain Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Brain Biomarker Revenue
3.4 Global Brain Biomarker Market Concentration Ratio
3.4.1 Global Brain Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Biomarker Revenue in 2020
3.5 Brain Biomarker Key Players Head office and Area Served
3.6 Key Players Brain Biomarker Product Solution and Service
3.7 Date of Enter into Brain Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Biomarker Breakdown Data by Type
4.1 Global Brain Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Brain Biomarker Forecasted Market Size by Type (2022-2027)

5 Brain Biomarker Breakdown Data by Application
5.1 Global Brain Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Brain Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Brain Biomarker Market Size (2016-2027)
6.2 North America Brain Biomarker Market Size by Type
6.2.1 North America Brain Biomarker Market Size by Type (2016-2021)
6.2.2 North America Brain Biomarker Market Size by Type (2022-2027)
6.2.3 North America Brain Biomarker Market Size by Type (2016-2027)
6.3 North America Brain Biomarker Market Size by Application
6.3.1 North America Brain Biomarker Market Size by Application (2016-2021)
6.3.2 North America Brain Biomarker Market Size by Application (2022-2027)
6.3.3 North America Brain Biomarker Market Size by Application (2016-2027)
6.4 North America Brain Biomarker Market Size by Country
6.4.1 North America Brain Biomarker Market Size by Country (2016-2021)
6.4.2 North America Brain Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Brain Biomarker Market Size (2016-2027)
7.2 Europe Brain Biomarker Market Size by Type
7.2.1 Europe Brain Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Brain Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Brain Biomarker Market Size by Type (2016-2027)
7.3 Europe Brain Biomarker Market Size by Application
7.3.1 Europe Brain Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Brain Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Brain Biomarker Market Size by Application (2016-2027)
7.4 Europe Brain Biomarker Market Size by Country
7.4.1 Europe Brain Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Brain Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Brain Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Brain Biomarker Market Size by Type
8.2.1 Asia-Pacific Brain Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Brain Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Brain Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Brain Biomarker Market Size by Application
8.3.1 Asia-Pacific Brain Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Brain Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Brain Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Brain Biomarker Market Size by Region
8.4.1 Asia-Pacific Brain Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Brain Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Brain Biomarker Market Size (2016-2027)
9.2 Latin America Brain Biomarker Market Size by Type
9.2.1 Latin America Brain Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Brain Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Brain Biomarker Market Size by Type (2016-2027)
9.3 Latin America Brain Biomarker Market Size by Application
9.3.1 Latin America Brain Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Brain Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Brain Biomarker Market Size by Application (2016-2027)
9.4 Latin America Brain Biomarker Market Size by Country
9.4.1 Latin America Brain Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Brain Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Brain Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Brain Biomarker Market Size by Type
10.2.1 Middle East & Africa Brain Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Brain Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Brain Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Brain Biomarker Market Size by Application
10.3.1 Middle East & Africa Brain Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Brain Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Brain Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Brain Biomarker Market Size by Country
10.4.1 Middle East & Africa Brain Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Brain Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Details
11.1.2 Philips Business Overview
11.1.3 Philips Brain Biomarker Introduction
11.1.4 Philips Revenue in Brain Biomarker Business (2016-2021)
11.1.5 Philips Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Brain Biomarker Introduction
11.2.4 Johnson & Johnson Revenue in Brain Biomarker Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Brain Biomarker Introduction
11.3.4 Roche Revenue in Brain Biomarker Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Seimens
11.4.1 Seimens Company Details
11.4.2 Seimens Business Overview
11.4.3 Seimens Brain Biomarker Introduction
11.4.4 Seimens Revenue in Brain Biomarker Business (2016-2021)
11.4.5 Seimens Recent Development
11.5 GE
11.5.1 GE Company Details
11.5.2 GE Business Overview
11.5.3 GE Brain Biomarker Introduction
11.5.4 GE Revenue in Brain Biomarker Business (2016-2021)
11.5.5 GE Recent Development
11.6 NeuroVista
11.6.1 NeuroVista Company Details
11.6.2 NeuroVista Business Overview
11.6.3 NeuroVista Brain Biomarker Introduction
11.6.4 NeuroVista Revenue in Brain Biomarker Business (2016-2021)
11.6.5 NeuroVista Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Brain Biomarker Introduction
11.7.4 Qiagen Revenue in Brain Biomarker Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Lifesign
11.8.1 Lifesign Company Details
11.8.2 Lifesign Business Overview
11.8.3 Lifesign Brain Biomarker Introduction
11.8.4 Lifesign Revenue in Brain Biomarker Business (2016-2021)
11.8.5 Lifesign Recent Development
11.9 Natus
11.9.1 Natus Company Details
11.9.2 Natus Business Overview
11.9.3 Natus Brain Biomarker Introduction
11.9.4 Natus Revenue in Brain Biomarker Business (2016-2021)
11.9.5 Natus Recent Development
11.10 BrainScope
11.10.1 BrainScope Company Details
11.10.2 BrainScope Business Overview
11.10.3 BrainScope Brain Biomarker Introduction
11.10.4 BrainScope Revenue in Brain Biomarker Business (2016-2021)
11.10.5 BrainScope Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Brain Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biomarker Test Kits
Table 3. Key Players of Biomarker Analyzers
Table 4. Global Brain Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Brain Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Brain Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Brain Biomarker Market Share by Regions (2016-2021)
Table 8. Global Brain Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Brain Biomarker Market Share by Regions (2022-2027)
Table 10. Brain Biomarker Market Trends
Table 11. Brain Biomarker Market Drivers
Table 12. Brain Biomarker Market Challenges
Table 13. Brain Biomarker Market Restraints
Table 14. Global Brain Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Brain Biomarker Market Share by Players (2016-2021)
Table 16. Global Top Brain Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Biomarker as of 2020)
Table 17. Ranking of Global Top Brain Biomarker Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Brain Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Brain Biomarker Product Solution and Service
Table 21. Date of Enter into Brain Biomarker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Brain Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Brain Biomarker Revenue Market Share by Type (2016-2021)
Table 25. Global Brain Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Brain Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Brain Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Brain Biomarker Revenue Market Share by Application (2016-2021)
Table 29. Global Brain Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Brain Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Brain Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Brain Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Brain Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Brain Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Brain Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Brain Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Brain Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Brain Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Brain Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Brain Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Brain Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Brain Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Brain Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Brain Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Brain Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Brain Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Brain Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Brain Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Brain Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Brain Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Brain Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Brain Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Brain Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Brain Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Brain Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Brain Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Brain Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Brain Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Brain Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Brain Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 61. Philips Company Details
Table 62. Philips Business Overview
Table 63. Philips Brain Biomarker Product
Table 64. Philips Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 65. Philips Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Brain Biomarker Product
Table 69. Johnson & Johnson Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Brain Biomarker Product
Table 74. Roche Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Seimens Company Details
Table 77. Seimens Business Overview
Table 78. Seimens Brain Biomarker Product
Table 79. Seimens Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 80. Seimens Recent Development
Table 81. GE Company Details
Table 82. GE Business Overview
Table 83. GE Brain Biomarker Product
Table 84. GE Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 85. GE Recent Development
Table 86. NeuroVista Company Details
Table 87. NeuroVista Business Overview
Table 88. NeuroVista Brain Biomarker Product
Table 89. NeuroVista Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 90. NeuroVista Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Brain Biomarker Product
Table 94. Qiagen Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 95. Qiagen Recent Development
Table 96. Lifesign Company Details
Table 97. Lifesign Business Overview
Table 98. Lifesign Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 99. Lifesign Recent Development
Table 100. Natus Company Details
Table 101. Natus Business Overview
Table 102. Natus Brain Biomarker Product
Table 103. Natus Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 104. Natus Recent Development
Table 105. BrainScope Company Details
Table 106. BrainScope Business Overview
Table 107. BrainScope Brain Biomarker Product
Table 108. BrainScope Revenue in Brain Biomarker Business (2016-2021) & (US$ Million)
Table 109. BrainScope Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Biomarker Test Kits Features
Figure 3. Biomarker Analyzers Features
Figure 4. Global Brain Biomarker Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Brain Biomarker Report Years Considered
Figure 9. Global Brain Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Brain Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Brain Biomarker Market Share by Regions: 2020 VS 2027
Figure 12. Global Brain Biomarker Market Share by Regions (2022-2027)
Figure 13. Global Brain Biomarker Market Share by Players in 2020
Figure 14. Global Top Brain Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Biomarker as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Brain Biomarker Revenue in 2020
Figure 16. Global Brain Biomarker Revenue Market Share by Type (2016-2021)
Figure 17. Global Brain Biomarker Revenue Market Share by Type (2022-2027)
Figure 18. North America Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Brain Biomarker Market Share by Type (2016-2027)
Figure 20. North America Brain Biomarker Market Share by Application (2016-2027)
Figure 21. North America Brain Biomarker Market Share by Country (2016-2027)
Figure 22. United States Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Brain Biomarker Market Share by Type (2016-2027)
Figure 26. Europe Brain Biomarker Market Share by Application (2016-2027)
Figure 27. Europe Brain Biomarker Market Share by Country (2016-2027)
Figure 28. Germany Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Brain Biomarker Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Brain Biomarker Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Brain Biomarker Market Share by Region (2016-2027)
Figure 38. China Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Brain Biomarker Market Share by Type (2016-2027)
Figure 46. Latin America Brain Biomarker Market Share by Application (2016-2027)
Figure 47. Latin America Brain Biomarker Market Share by Country (2016-2027)
Figure 48. Mexico Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Brain Biomarker Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Brain Biomarker Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Brain Biomarker Market Share by Country (2016-2027)
Figure 54. Turkey Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Brain Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Philips Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 60. Seimens Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 61. GE Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 62. NeuroVista Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 63. Qiagen Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 64. Lifesign Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 65. Natus Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 66. BrainScope Revenue Growth Rate in Brain Biomarker Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---